• Dr. Vladislav Deigin, Ph.D., Dr.Sc. – President
• Yuri Deigin, MBA – CEO
• Janko Peric – VP Public Relations
• Karen Zhou – VP International Development
Dr. Vladislav Deigin is the founder of Manus Pharmaceuticals. Dr. Deigin has been the driving force behind the scientific research in peptide-based preparations for the drug patents held by Manus. Dr. Deigin has over 40 years of experience in the field of scientific research. He served as a Member of the Innovation Committee of the Supreme Soviet of the Russian Federation (parliamentary adviser) from 1992 to 1993. Dr. Deigin was the Deputy Minister of the Public Health of the Russian Federation from 1990 to 1992, and he served as the Director General of All Union Peptide Engineering Center Peptos, USSR Academy of Sciences from 1989 to 1990. He currently serves as head of the biopharmaceutical lab in the world renown Shemyakin&Ovchinnikov Institute of Bioorganic chemistry of Russian Academy of Sciences. Dr. Deigin was granted the professor and Doctor of Sciences degree in Biology and Immunology in 2000, and received his Ph.D. in Bioorganic Chemistry and Biotechnology in 1983.
Yuri Deigin serves as CEO of Manus Pharmaceuticals. Yuri has over a decade of entrepreneurial and fundraising experience in diverse industries ranging from IT to biotech and pharmaceuticals. In this decade, he has established relationships with several venture capital funds, including funds in Moscow, Toronto, Boston, and New York. In his role at Manus, Yuri is responsible for all business-related endeavours, including fundraising, global partnerships, IP and legal strategy. Yuri holds a B.Sc. of Computer Science from the University of Toronto and an MBA from Columbia Business School.
Janko Peric serves as the Vice President of Public Relations of Manus Pharmaceuticals. Janko is a Graduate from the Technical School of Zagreb. Janko has consulted for various industries and served as a Member of Canadian Parliament from 1993-2004.
Karen Zhou has more than 20 years of experience in international investment, trading and marketing development, especially in the medical field. Over the years Karen established strong business networks and successfully sole-represented and cooperated with many world leading companies.